Photocrosslinkable gelatin-treated dentin matrix hydrogel as a novel pulp capping agent for dentin regeneration: I. synthesis, characterizations and grafting optimization.
Dentin matrix
Dentin regeneration
Gelatin
Glycine
Injectable scaffold
Pulp capping
Riboflavin
Journal
BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684
Informations de publication
Date de publication:
04 08 2023
04 08 2023
Historique:
received:
20
04
2023
accepted:
18
07
2023
medline:
7
8
2023
pubmed:
5
8
2023
entrez:
4
8
2023
Statut:
epublish
Résumé
In recent years, treated dentin matrix (TDM) has been introduced as a bioactive hydrogel for dentin regeneration in DPC. However, no study has introduced TDM as a photocrosslinkable hydrogel with a natural photoinitiating system. Therefore, the present study aimed to explore the synthesis, characterizations and grafting optimization of injectable gelatin- glycidyl methacrylate (GMA)/TDM hydrogels as a novel photocrosslinkable pulp capping agent for dentin regeneration. G-GMA/TDM hydrogel was photocrosslinked using a new two-component photoinitiating system composed of riboflavin as a photoinitiator under visible light and glycine as a first time coinitiator with riboflavin. The grafting reaction conditions of G-GMA/TDM e.g. GMA concentration and reaction time were optimized. The kinetic parameters e.g. grafting efficiency (GE) and grafting percentage (GP%) were calculated to optimize the grafting reaction, while yield (%) was determined to monitor the formation of the hydrogel. Moreover, G-GMA/TDM hydrogels were characterized by swelling ratio, degradation degree, and cytotoxicity. The instrumental characterizations e.g. FTIR, The grafting reaction dramatically increased with an increase of both GMA concentration and reaction time. It was realized that the swelling degree and degradation rate of G-GMA/TDM hydrogels were significantly reduced by increasing the GMA concentration and prolonging the reaction time. When compared to the safe low and moderate GMA content hydrogels (0.048, 0.097 M) and shorter reaction times (6, 12, 24 h), G-GMA/TDM with high GMA contents (0.195, 0.391 M) and a prolonged reaction time (48 h) demonstrated cytotoxic effects against cells using the MTT assay. Also, the morphological surface of G-GMA/TDM freeze-dried gels was found more compacted, smooth and uniform due to the grafting process. Significant thermal stability was noticed due to the grafting reaction of G-GMA/TDM throughout the TGA results. G-GMA/TDM composite hydrogel formed by the riboflavin/glycine photoinitiating system is a potential bioactive and biocompatible system for in-situ crosslinking the activated-light pulp capping agent for dentin regeneration.
Sections du résumé
BACKGROUND
In recent years, treated dentin matrix (TDM) has been introduced as a bioactive hydrogel for dentin regeneration in DPC. However, no study has introduced TDM as a photocrosslinkable hydrogel with a natural photoinitiating system. Therefore, the present study aimed to explore the synthesis, characterizations and grafting optimization of injectable gelatin- glycidyl methacrylate (GMA)/TDM hydrogels as a novel photocrosslinkable pulp capping agent for dentin regeneration.
METHODS
G-GMA/TDM hydrogel was photocrosslinked using a new two-component photoinitiating system composed of riboflavin as a photoinitiator under visible light and glycine as a first time coinitiator with riboflavin. The grafting reaction conditions of G-GMA/TDM e.g. GMA concentration and reaction time were optimized. The kinetic parameters e.g. grafting efficiency (GE) and grafting percentage (GP%) were calculated to optimize the grafting reaction, while yield (%) was determined to monitor the formation of the hydrogel. Moreover, G-GMA/TDM hydrogels were characterized by swelling ratio, degradation degree, and cytotoxicity. The instrumental characterizations e.g. FTIR,
RESULTS
The grafting reaction dramatically increased with an increase of both GMA concentration and reaction time. It was realized that the swelling degree and degradation rate of G-GMA/TDM hydrogels were significantly reduced by increasing the GMA concentration and prolonging the reaction time. When compared to the safe low and moderate GMA content hydrogels (0.048, 0.097 M) and shorter reaction times (6, 12, 24 h), G-GMA/TDM with high GMA contents (0.195, 0.391 M) and a prolonged reaction time (48 h) demonstrated cytotoxic effects against cells using the MTT assay. Also, the morphological surface of G-GMA/TDM freeze-dried gels was found more compacted, smooth and uniform due to the grafting process. Significant thermal stability was noticed due to the grafting reaction of G-GMA/TDM throughout the TGA results.
CONCLUSIONS
G-GMA/TDM composite hydrogel formed by the riboflavin/glycine photoinitiating system is a potential bioactive and biocompatible system for in-situ crosslinking the activated-light pulp capping agent for dentin regeneration.
Identifiants
pubmed: 37542230
doi: 10.1186/s12903-023-03236-z
pii: 10.1186/s12903-023-03236-z
pmc: PMC10401831
doi:
Substances chimiques
Gelatin
9000-70-8
Pulp Capping and Pulpectomy Agents
0
Hydrogels
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
536Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Tissue Eng Part A. 2012 Apr;18(7-8):677-91
pubmed: 21988658
Biotechnol Bioeng. 2003 Jun 5;82(5):578-89
pubmed: 12652481
Biomaterials. 2003 Oct;24(23):4301-13
pubmed: 12853261
J Biomed Mater Res. 2000 Mar 15;49(4):517-27
pubmed: 10602085
Biomater Res. 2022 Apr 5;26(1):12
pubmed: 35382888
Int J Pharm. 2017 Apr 15;521(1-2):249-258
pubmed: 28232268
Biomaterials. 2015 Jun;52:56-70
pubmed: 25818413
Clin Oral Investig. 2021 Jul;25(7):4621-4634
pubmed: 33507394
RSC Adv. 2021 Apr 21;11(25):14996-15009
pubmed: 35424032
Biomater Sci. 2018 May 1;6(5):915-946
pubmed: 29492503
J Biomed Mater Res A. 2004 Jan 1;68(1):28-33
pubmed: 14661246
J Biomater Appl. 2018 Oct;33(4):477-487
pubmed: 30217134
J Taibah Univ Med Sci. 2021 Feb 23;16(4):529-539
pubmed: 34408610
Biomimetics (Basel). 2021 Apr 20;6(2):
pubmed: 33924063
J Mater Chem B. 2015 Apr 14;3(14):2842-2852
pubmed: 32262413
J Mater Sci Mater Med. 2016 Nov;27(11):164
pubmed: 27655430
Clin Oral Investig. 2021 Apr;25(4):2101-2112
pubmed: 32815038
Genet Mol Res. 2017 Sep 27;16(3):
pubmed: 28973756
Acta Biomater. 2009 Nov;5(9):3441-52
pubmed: 19505599
J Tissue Eng Regen Med. 2017 Dec;11(12):3428-3436
pubmed: 28198096
J Conserv Dent. 2020 Jul-Aug;23(4):384-389
pubmed: 33623241
Eur J Oral Sci. 2012 Aug;120(4):259-68
pubmed: 22813215
RSC Adv. 2019 Jun 5;9(31):17737-17744
pubmed: 35520570
Mar Drugs. 2019 Jan 10;17(1):
pubmed: 30634553
Cell Tissue Bank. 2015 Dec;16(4):559-68
pubmed: 25700693
Iran Endod J. 2022;17(4):185-194
pubmed: 36703697
Int J Biol Macromol. 2018 Sep;116:1175-1185
pubmed: 29777818
Biotechnol Lett. 2007 Jan;29(1):17-25
pubmed: 17091377
Biomaterials. 2011 Jul;32(20):4525-38
pubmed: 21458067
Int Endod J. 2018 Aug;51(8):877-888
pubmed: 29377169
BMC Oral Health. 2023 Feb 25;23(1):126
pubmed: 36841767
Acta Biomater. 2012 May;8(5):1838-48
pubmed: 22285429
Mater Sci Eng C Mater Biol Appl. 2021 Apr;123:111694
pubmed: 33812568
Acta Biomater. 2015 Apr;16:60-70
pubmed: 25644448
Biomolecules. 2020 Dec 29;11(1):
pubmed: 33383963
J Biomater Appl. 2019 Jan;33(6):834-853
pubmed: 30458663
Gels. 2022 May 15;8(5):
pubmed: 35621600